Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

13drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Nivo+Ipi ×

Nivo+Ipi

This drug is selected. Its supporting articles are shown below.

Articles mentioning Nivo+Ipi

2 articles · page 1 of 1

Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF-mutant advanced melanoma: A matching-adjusted indirect comparison

bmjonc · full text · 2025-12-14 · 11 matching annotations

95.2%

encorafenib vemurafenib binimetinib cobimetinib dabrafenib NIVO+RELA atezolizumab nivolumab trametinib NIVO+IPI

…TEZO, atezolizumab; BINI, binimetinib; COBI, cobimetinib; ENCO, encorafenib; ESS, effective sample size; DAB, dabrafenib; NIVO, nivolumab; …

PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC

jitc · abstract · 2025-12-05 · 2 matching annotations

84.0%

nivolumab ipilimumab Pembro pembrolizumab-based Nivo Nivo+Ipi Ipi NSCLC

…emotherapy, pembrolizumab-based chemoimmunotherapy (Pembro) and nivolumab plus ipilimumab with or without two cycles of platinum-doublet …